Alyssa K. Mezochow, Marcus R. Pereira, Juan Ortega-Legaspi, Thresiamma Lukose, Warren B. Bilker, Teresa Wang, Pam Tolomeo, Jacqueline Omorogbe, Olaoluwa Olaiya, Zane Bekheet, John Janosevic, Ebbing Lautenbach
{"title":"Changes in bloodstream infections in heart transplant recipients following the allocation guidelines change","authors":"Alyssa K. Mezochow, Marcus R. Pereira, Juan Ortega-Legaspi, Thresiamma Lukose, Warren B. Bilker, Teresa Wang, Pam Tolomeo, Jacqueline Omorogbe, Olaoluwa Olaiya, Zane Bekheet, John Janosevic, Ebbing Lautenbach","doi":"10.1016/j.ajt.2026.05.2294","DOIUrl":null,"url":null,"abstract":"<div><div>In 2018, the orthotopic heart transplant (OHT) allocation policy in the United States changed to prioritize more critically ill candidates, including those supported with temporary mechanical circulatory support (tMCS). This study evaluated changes in posttransplant bloodstream infection (BSI) rates following the OHT allocation change. We conducted a retrospective cohort study of OHT recipients at 2 large United States transplant centers from January 1, 2015, to December 31, 2022. Recipients were followed 90 days post-OHT for BSIs. The association between policy era and BSIs was evaluated using multivariable Cox regression with mediation analysis to explore the effect of tMCS. There were 895 OHT recipients with a nearly two-fold increase in pretransplant tMCS after the policy change. Seventy-nine recipients developed BSIs (8.8%). OHT in the postpolicy era was associated with a 1.9-fold increased hazard of BSI (<em>P</em> = 0.018). Mediation analysis showed tMCS acted as a significant mediator of increased BSI risk after the change. One-year mortality and graft failure were similar across the 2 policy eras, although there was a significant decrease in 1-year rejection following the change (<em>P</em> < .001). Overall, post-OHT BSI risk nearly doubled following the allocation change, which is mediated by tMCS. Additional studies are needed to further investigate factors contributing to BSI risk.</div></div>","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"26 10","pages":"Pages 2394-2402"},"PeriodicalIF":8.1000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Transplantation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1600613526025657","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
In 2018, the orthotopic heart transplant (OHT) allocation policy in the United States changed to prioritize more critically ill candidates, including those supported with temporary mechanical circulatory support (tMCS). This study evaluated changes in posttransplant bloodstream infection (BSI) rates following the OHT allocation change. We conducted a retrospective cohort study of OHT recipients at 2 large United States transplant centers from January 1, 2015, to December 31, 2022. Recipients were followed 90 days post-OHT for BSIs. The association between policy era and BSIs was evaluated using multivariable Cox regression with mediation analysis to explore the effect of tMCS. There were 895 OHT recipients with a nearly two-fold increase in pretransplant tMCS after the policy change. Seventy-nine recipients developed BSIs (8.8%). OHT in the postpolicy era was associated with a 1.9-fold increased hazard of BSI (P = 0.018). Mediation analysis showed tMCS acted as a significant mediator of increased BSI risk after the change. One-year mortality and graft failure were similar across the 2 policy eras, although there was a significant decrease in 1-year rejection following the change (P < .001). Overall, post-OHT BSI risk nearly doubled following the allocation change, which is mediated by tMCS. Additional studies are needed to further investigate factors contributing to BSI risk.
期刊介绍:
The American Journal of Transplantation is a leading journal in the field of transplantation. It serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science. Published monthly, it provides an essential resource for researchers and clinicians worldwide.
The journal publishes original articles, case reports, invited reviews, letters to the editor, critical reviews, news features, consensus documents, and guidelines over 12 issues a year. It covers all major subject areas in transplantation, including thoracic (heart, lung), abdominal (kidney, liver, pancreas, islets), tissue and stem cell transplantation, organ and tissue donation and preservation, tissue injury, repair, inflammation, and aging, histocompatibility, drugs and pharmacology, graft survival, and prevention of graft dysfunction and failure. It also explores ethical and social issues in the field.